Drug Shortage Report for DEXTROSE INJECTION USP
Report ID | 61848 |
Drug Identification Number | 00037966 |
Brand name | DEXTROSE INJECTION USP |
Common or Proper name | Dextrose 20% Injection USP |
Company Name | ICU MEDICAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | DEXTROSE |
Strength(s) | 200MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 20 g/100 ml |
ATC code | B05BA |
ATC description | I.V. SOLUTIONS |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2018-09-19 |
Actual start date | 2018-09-19 |
Estimated end date | 2018-11-19 |
Actual end date | 2019-10-31 |
Shortage status | Resolved |
Updated date | 2020-02-20 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2600 BOUL ALFRED-NOBEL, SUITE 100 SAINT LAURENT, QUEBEC CANADA H4S 0A9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-02-20 | French | Compare |
v5 | 2020-02-20 | English | Compare |
v4 | 2019-10-31 | English | Compare |
v3 | 2018-10-16 | English | Compare |
v2 | 2018-10-09 | English | Compare |
v1 | 2018-09-19 | English | Compare |
Showing 1 to 6 of 6